Medications for Scedosporiosis

5 results

  • Vfend (voriconazole)

    (Voriconazole)
    Roerig
    Usage: VFEND is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in adults and pediatric patients (2 years and older) intolerant to or refractory to other therapies.

  • Voriconazole (voriconazole)

    (voriconazole)
    Sandoz Inc
    Usage: Voriconazole tablets are indicated for the treatment of invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older, particularly those intolerant or refractory to other therapies.

  • Voriconazole (voriconazole)

    (Voriconazole)
    Greenstone LLC
    Usage: Voriconazole is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. in patients 2 years and older who are intolerant or refractory to other therapies.

  • Voriconazole (voriconazole)

    (voriconazole)
    Slate Run Pharmaceuticals
    Usage: Voriconazole for injection is indicated for adults and pediatric patients (2 years and older) to treat invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium species, especially when other therapies are ineffective or intolerable.

  • Voriconazole (voriconazole)

    (Voriconazole)
    Eugia US LLC
    Usage: Voriconazole for injection is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients intolerant to or refractory to other therapies. Suitable for adults and pediatric patients aged 2 years and older.